Equities

Nexalin Technology Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NXL:NAQ

Nexalin Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.40
  • Today's Change-0.053 / -11.62%
  • Shares traded219.00
  • 1 Year change-87.92%
  • Beta4.1264
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It has also designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.

  • Revenue in USD (TTM)156.94k
  • Net income in USD-8.68m
  • Incorporated2010
  • Employees6.00
  • Location
    Nexalin Technology Inc1776 Yorktown, Suite 550HOUSTON 77056United StatesUSA
  • Phone+1 (832) 260-0222
  • Websitehttps://nexalin.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ADM Tronics Unlimited Inc3.36m-129.58k6.02m7.00--6.8317.111.79-0.0019-0.00190.04970.0131.474.956.60---5.67-17.71-10.33-27.7539.0740.78-3.86-19.080.8633-3.740.3461--7.81-1.7285.97------
Innovative Eyewear Inc2.39m-7.85m6.15m11.00--0.584--2.57-2.63-2.630.73691.970.21011.4529.13217,504.50-68.92-143.06-73.91-176.8022.844.06-327.98-574.8910.13--0.00--41.99220.75-16.55------
iTonic Holdings Ltd305.22k-2.41m6.56m10.00--1.39--21.51-0.1637-0.16370.02150.27750.09430.62922.0230,522.00-74.52---100.07--82.86---790.56--11.36--0.0287---28.70---173.85------
Biomerica Inc4.46m-4.03m6.73m53.00--1.48--1.51-1.64-1.641.761.500.672.543.9284,113.21-60.49-51.40-81.87-60.825.6111.63-90.29-71.362.29--0.00---1.92-4.5216.81---20.83--
Kelyniam Global Inc-100.00bn-100.00bn7.07m0.00--9.59----------0.0146------------------------0.6993--0.3831--------------
INVO Fertility Inc6.94m-27.13m7.10m28.00------1.02-3,149.24-3,191.0251.458.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Scientific Industries Inc8.95m-1.24m7.16m67.00--0.5743--0.7994-0.1394-0.13890.80271.040.64261.538.80133,628.40-8.91---10.06--41.46---13.87--6.34--0.00---3.59--29.09------
Dror Ortho-Design Inc0.00-3.12m7.18m3.00---------0.0033-0.00330.00-0.00240.00----0.00-405.89-214.68---759.55-------276,220.70---69.87---------61.89------
Biotricity Inc15.45m-4.70m7.22m46.00------0.4676-0.1759-0.17590.5776-1.162.651.6510.98335,874.10-68.80-229.45----81.0964.92-25.99-184.400.12630.0323----14.3257.6120.01------
Nexalin Technology Inc156.94k-8.68m7.46m6.00--1.53--47.54-0.6345-0.63450.01090.26220.03020.300413.5926,156.67-167.17-166.16-178.46-334.5469.5176.06-5,530.09-1,178.9513.03--0.00--52.34-4.04-63.64------
Meihua International Medical Tech Co Ltd89.55m9.27m7.71m619.000.26350.01730.78490.086134.1234.12302.14520.790.484453.651.05144,664.905.029.695.9011.6934.3137.0210.3513.995.6689.960.06490.00-0.19494.01-6.73-6.81-56.87--
AccuStem Sciences Inc0.00-1.61m8.26m2.00---------0.1163-0.11630.00-0.18110.00----0.00-192.46--------------------------26.60------
Tenon Medical Inc3.23m-12.81m8.65m27.00--3.99--2.68-2.76-2.760.57250.55760.27631.562.96119,740.70-109.47-174.04-149.09-976.4552.4034.39-396.26-788.171.70--0.00--11.92127.6112.25------
SeaStar Medical Holding Corp881.00k-13.67m8.72m19.00--0.7198--9.90-16.43-16.430.68743.360.0876--6.1046,368.42-135.86---290.37--95.35---1,551.08--3.64--0.00------5.34------
ALR Technologies SG Ltd9.49k-8.00m9.12m6.00------960.72-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
HeartSciences Inc8.67k-9.04m9.38m15.00--2.17--1,081.40-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
Data as of Feb 17 2026. Currency figures normalised to Nexalin Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

5.86%Per cent of shares held by top holders
HolderShares% Held
Peak6 Capital Management LLCas of 31 Dec 2025476.51k2.56%
Geode Capital Management LLCas of 31 Dec 2025150.27k0.81%
The Vanguard Group, Inc.as of 31 Dec 2025126.54k0.68%
Renaissance Technologies LLCas of 31 Dec 2025122.10k0.66%
G1 Execution Services LLCas of 30 Sep 202562.50k0.34%
Vanguard Fiduciary Trust Co.as of 31 Dec 202551.39k0.28%
Jane Street Capital LLCas of 31 Dec 202535.02k0.19%
SSgA Funds Management, Inc.as of 31 Dec 202532.30k0.17%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 202524.10k0.13%
XTX Markets LLCas of 30 Sep 202511.91k0.06%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.